Lv210
186 积分 2023-12-20 加入
Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung Cancer
3天前
已关闭
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
3天前
已完结
Immune checkpoint inhibitors as neoadjuvant therapy for resectable non-small cell lung cancer: a systematic review and network meta-analysis
3天前
已完结
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
9天前
已完结
Lessons from neoadjuvant immunotherapy in melanoma: understanding antitumour immunity and tumour escape
20天前
已完结
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
25天前
已完结
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
25天前
已完结
Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma
26天前
已完结
Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial
26天前
已完结
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
26天前
已完结
皖公网安备34019202002308
